1. Home
  2. RLMD vs GPRO Comparison

RLMD vs GPRO Comparison

Compare RLMD & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • GPRO
  • Stock Information
  • Founded
  • RLMD 2004
  • GPRO 2004
  • Country
  • RLMD United States
  • GPRO United States
  • Employees
  • RLMD N/A
  • GPRO N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • GPRO Industrial Machinery/Components
  • Sector
  • RLMD Health Care
  • GPRO Consumer Discretionary
  • Exchange
  • RLMD Nasdaq
  • GPRO Nasdaq
  • Market Cap
  • RLMD 289.7M
  • GPRO 282.4M
  • IPO Year
  • RLMD N/A
  • GPRO 2014
  • Fundamental
  • Price
  • RLMD $4.22
  • GPRO $1.61
  • Analyst Decision
  • RLMD Buy
  • GPRO
  • Analyst Count
  • RLMD 2
  • GPRO 0
  • Target Price
  • RLMD $5.50
  • GPRO N/A
  • AVG Volume (30 Days)
  • RLMD 2.1M
  • GPRO 4.3M
  • Earning Date
  • RLMD 11-13-2025
  • GPRO 11-06-2025
  • Dividend Yield
  • RLMD N/A
  • GPRO N/A
  • EPS Growth
  • RLMD N/A
  • GPRO N/A
  • EPS
  • RLMD N/A
  • GPRO N/A
  • Revenue
  • RLMD N/A
  • GPRO $650,751,000.00
  • Revenue This Year
  • RLMD N/A
  • GPRO N/A
  • Revenue Next Year
  • RLMD N/A
  • GPRO $9.72
  • P/E Ratio
  • RLMD N/A
  • GPRO N/A
  • Revenue Growth
  • RLMD N/A
  • GPRO N/A
  • 52 Week Low
  • RLMD $0.24
  • GPRO $0.40
  • 52 Week High
  • RLMD $5.12
  • GPRO $3.05
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 72.46
  • GPRO 43.65
  • Support Level
  • RLMD $3.81
  • GPRO $1.41
  • Resistance Level
  • RLMD $5.12
  • GPRO $1.66
  • Average True Range (ATR)
  • RLMD 0.55
  • GPRO 0.12
  • MACD
  • RLMD 0.05
  • GPRO 0.01
  • Stochastic Oscillator
  • RLMD 64.44
  • GPRO 46.05

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

Share on Social Networks: